get oral semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients For patients with #obesity, semaglutide,

This long half-life also means that if you inject a few hours early or late, the pharmacological impact is negligible

10.1038/s41467-019-09277-9 Nat

(PubMed) Rochette L, Ghibu S, Richard C, Zeller M, Cottin Y, Vergely C

While these drugs were initially used for the primary purpose of lowering blood glucose in people with type 2 diabetes, the satiety side effect and slower digestion also resulted in lower overall hunger, fewer cravings (particularly for fatty and sugary foods), and ultimately significant weight loss

when stored as directed, the peptide maintains stability for up to 24 months

NHS and NICE-aligned measures include eating smaller, more frequent meals, avoiding fatty or spicy foods, remaining upright after eating, and using alginate preparations such as Gaviscon Advance as a first-line option